What is the intrinsic value of STAA?
As of 2026-09-17, the Intrinsic Value of STAAR Surgical Co (STAA) is
0.39 USD. This STAA valuation is based on the model Peter Lynch Fair Value.
With the current market price of 22.41 USD, the upside of STAAR Surgical Co is
-98.28%.
Is STAA undervalued or overvalued?
Based on its market price of 22.41 USD and our intrinsic valuation, STAAR Surgical Co (STAA) is overvalued by 98.28%.
STAA Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(517.01) - (3.25) |
(8.45) |
-137.7% |
| DCF (Growth 10y) |
(3.75) - (572.04) |
(9.60) |
-142.9% |
| DCF (EBITDA 5y) |
(9.60) - (32.49) |
(1,234.50) |
-123450.0% |
| DCF (EBITDA 10y) |
(5.55) - (44.23) |
(1,234.50) |
-123450.0% |
| Fair Value |
0.39 - 0.39 |
0.39 |
-98.28% |
| P/E |
2.29 - 4.08 |
2.97 |
-86.8% |
| EV/EBITDA |
20.84 - 24.41 |
22.00 |
-1.8% |
| EPV |
2.16 - (2.75) |
(0.29) |
-101.3% |
| DDM - Stable |
0.82 - 3.30 |
2.06 |
-90.8% |
| DDM - Multi |
(17.75) - (55.98) |
(27.00) |
-220.5% |
STAA Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
1,115.79 |
| Beta |
0.96 |
| Outstanding shares (mil) |
49.79 |
| Enterprise Value (mil) |
967.21 |
| Market risk premium |
4.60% |
| Cost of Equity |
8.34% |
| Cost of Debt |
47.38% |
| WACC |
21.40% |